Profil
Göran Tornling currently works at AcuCort AB, as Independent Director from 2021, Karolinska Institutet, as Associate Professor, Biolipox AB, as Chief Medical Officer & Vice President from 2006, and AnaMar AB, as Chief Medical Officer.
Dr. Tornling also formerly worked at AstraZeneca R&D Boston, Inc., as Director-Medical Science.
Dr. Tornling received his doctorate degree from Karolinska Institutet.
Postes actifs de Göran Tornling
| Sociétés | Poste | Début |
|---|---|---|
| ACUCORT AB | Directeur/Membre du Conseil | 01/01/2021 |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Directeur Technique/Scientifique/R&D | 01/09/2006 |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Göran Tornling
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Corporate Officer/Principal | - |
Formation de Göran Tornling
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Health Technology |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Health Technology |
AcuCort AB
AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
















